Evan Greger is the founder of Pionyr Immunotherapeutics. Pionyr Immunotherapeutics has raised $62M in total funding. Latest round: Series B.
Evan Greger was an early employee at Pionyr Immunotherapeutics, a company focused on developing antibody-based immuno-oncology therapeutics. The company has engaged in contract development and manufacturing projects with partners like ProBioGen and Lonza.
Full founder directory · Investor directory · Company funding database · Fundraising library